Literature DB >> 19865784

Molecular variation in neuropeptide Y and bone mineral density among men of African ancestry.

Louis J Goodrich1, Laura M Yerges-Armstrong, Iva Miljkovic, Cara S Nestlerode, Allison L Kuipers, Clareann H Bunker, Alan L Patrick, Victor W Wheeler, Joseph M Zmuda.   

Abstract

Neuropeptide Y (NPY) is a physiological candidate gene for the regulation of body weight and has more recently been implicated in regulating bone mass. The current study sought to test if inherited variation in NPY might influence BMD in a population of African-ancestry men who have high bone mineral density (BMD). We genotyped 17 tagging single-nucleotide polymorphisms (SNPs) across the NPY gene region in 1,113 randomly selected men of African ancestry aged >or=40 years and tested for association with anthropometric characteristics and proximal femur BMD. The homozygous rare genotype of four SNPs was associated with a 0.92-1.59% decrease in stature (corrected P < 0.05). No SNP was associated with body mass index or body weight. Two SNPs in a 5-kb linkage disequilibrium block encompassing exons 3 and 4 were associated with proximal femur BMD, adjusted for age, body weight, and height (corrected P < 0.05). These results suggest that genetic variation at the NPY locus may contribute to bone density, independently of body weight.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19865784      PMCID: PMC4905686          DOI: 10.1007/s00223-009-9307-x

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  28 in total

1.  Analysis of single-locus tests to detect gene/disease associations.

Authors:  Kathryn Roeder; Silviu-Alin Bacanu; Vibhor Sonpar; Xiaohua Zhang; B Devlin
Journal:  Genet Epidemiol       Date:  2005-04       Impact factor: 2.135

Review 2.  NPY signalling pathway in bone homeostasis: Y1 receptor as a potential drug target.

Authors:  D M Sousa; H Herzog; M Lamghari
Journal:  Curr Drug Targets       Date:  2009-01       Impact factor: 3.465

3.  Many sequence variants affecting diversity of adult human height.

Authors:  Daniel F Gudbjartsson; G Bragi Walters; Gudmar Thorleifsson; Hreinn Stefansson; Bjarni V Halldorsson; Pasha Zusmanovich; Patrick Sulem; Steinunn Thorlacius; Arnaldur Gylfason; Stacy Steinberg; Anna Helgadottir; Andres Ingason; Valgerdur Steinthorsdottir; Elinborg J Olafsdottir; Gudridur H Olafsdottir; Thorvaldur Jonsson; Knut Borch-Johnsen; Torben Hansen; Gitte Andersen; Torben Jorgensen; Oluf Pedersen; Katja K Aben; J Alfred Witjes; Dorine W Swinkels; Martin den Heijer; Barbara Franke; Andre L M Verbeek; Diane M Becker; Lisa R Yanek; Lewis C Becker; Laufey Tryggvadottir; Thorunn Rafnar; Jeffrey Gulcher; Lambertus A Kiemeney; Augustine Kong; Unnur Thorsteinsdottir; Kari Stefansson
Journal:  Nat Genet       Date:  2008-04-06       Impact factor: 38.330

4.  Central autonomic control of the bone marrow: multisynaptic tract tracing by recombinant pseudorabies virus.

Authors:  A Dénes; Z Boldogkoi; G Uhereczky; A Hornyák; M Rusvai; M Palkovits; K J Kovács
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

Review 5.  Genetic regulation of bone mass and susceptibility to osteoporosis.

Authors:  Stuart H Ralston; Benoit de Crombrugghe
Journal:  Genes Dev       Date:  2006-09-15       Impact factor: 11.361

6.  Hypothalamic Y2 receptors regulate bone formation.

Authors:  Paul A Baldock; Amanda Sainsbury; Michelle Couzens; Ronaldo F Enriquez; Gethin P Thomas; Edith M Gardiner; Herbert Herzog
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

7.  Association studies of BMI and type 2 diabetes in the neuropeptide Y pathway: a possible role for NPY2R as a candidate gene for type 2 diabetes in men.

Authors:  Catarina D Campbell; Helen N Lyon; James Nemesh; Jared A Drake; Tiinamaija Tuomi; Daniel Gaudet; Xiaofeng Zhu; Richard S Cooper; Kristin G Ardlie; Leif C Groop; Joel N Hirschhorn
Journal:  Diabetes       Date:  2007-02-26       Impact factor: 9.461

8.  Correlates of bone mineral density in men of African ancestry: the Tobago bone health study.

Authors:  D D Hill; J A Cauley; Y Sheu; C H Bunker; A L Patrick; C E Baker; G L A Beckles; V W Wheeler; J M Zmuda
Journal:  Osteoporos Int       Date:  2007-09-14       Impact factor: 4.507

Review 9.  Growth hormone inhibits its own secretion by acting on the hypothalamus through its receptors on neuropeptide Y neurons in the arcuate nucleus and somatostatin neurons in the periventricular nucleus.

Authors:  S Minami; J Kamegai; H Sugihara; N Suzuki; I Wakabayashi
Journal:  Endocr J       Date:  1998-04       Impact factor: 2.349

10.  Identification of ten loci associated with height highlights new biological pathways in human growth.

Authors:  Guillaume Lettre; Anne U Jackson; Christian Gieger; Fredrick R Schumacher; Sonja I Berndt; Serena Sanna; Susana Eyheramendy; Benjamin F Voight; Johannah L Butler; Candace Guiducci; Thomas Illig; Rachel Hackett; Iris M Heid; Kevin B Jacobs; Valeriya Lyssenko; Manuela Uda; Michael Boehnke; Stephen J Chanock; Leif C Groop; Frank B Hu; Bo Isomaa; Peter Kraft; Leena Peltonen; Veikko Salomaa; David Schlessinger; David J Hunter; Richard B Hayes; Gonçalo R Abecasis; H-Erich Wichmann; Karen L Mohlke; Joel N Hirschhorn
Journal:  Nat Genet       Date:  2008-04-06       Impact factor: 38.330

View more
  1 in total

Review 1.  Molecular genetic studies of gene identification for osteoporosis: the 2009 update.

Authors:  Xiang-Hong Xu; Shan-Shan Dong; Yan Guo; Tie-Lin Yang; Shu-Feng Lei; Christopher J Papasian; Ming Zhao; Hong-Wen Deng
Journal:  Endocr Rev       Date:  2010-03-31       Impact factor: 19.871

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.